Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evogliptin/metformin - Dong-A ST

Next Previous
Drug Profile

Evogliptin/metformin - Dong-A ST

Alternative Names: DA-1229_01; Sugamet; Sugamet SR Tab 5/1000mg; SUGAMET®XR Tablet 5/1000mg

Latest Information Update: 21 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dong-A ST
  • Class Amides; Antihyperglycaemics; Biguanides; Fluorobenzenes; Piperazines; Small molecules
  • Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Type 2 diabetes mellitus

Most Recent Events

  • 14 Feb 2026 Dong-A ST completes a phase-I pharmacokinetics and safety trial (In volunteers) in South Korea (PO, Tablet) (NCT07342062)
  • 15 Jan 2026 Dong-A ST plans a phase-I pharmacokinetics and safety trial (In volunteers) in January 2026 (PO, Tablet) (NCT07342062)
  • 06 Jan 2026 Dong-A ST initiates a phase-I pharmacokinetics and safety trial (In volunteers) in South Korea (PO, Tablet) (NCT07342062)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top